Safety Database. BMS shall transfer to Company the safety database for the Licensed Compounds, in a mutually agreeable format, as soon as practicable subsequent to the Effective Date as agreed to by the Parties, and Company shall thereafter perform all responsibilities thereafter with respect to reporting of adverse events and pharmacovigilance relating to the Licensed Compounds.
Appears in 3 contracts
Samples: License Agreement (Immunome Inc.), License Agreement (Ayala Pharmaceuticals, Inc.), License Agreement (Ayala Pharmaceuticals, Inc.)
Safety Database. BMS shall transfer to Company the safety database for the Licensed Compounds, in a mutually agreeable formatthe form in which it is held by BMS, as soon as practicable subsequent to and in any event within [* * *] days after the Effective Date as agreed to by the PartiesDate, and Company shall thereafter perform all responsibilities thereafter with respect to reporting of adverse events and pharmacovigilance relating to the Licensed Compounds. If BMS learns of an adverse event based on work already carried out by BMS using a Licensed Compound, it will promptly notify Company of such adverse event.
Appears in 2 contracts
Samples: License Agreement (Biohaven Pharmaceutical Holding Co Ltd.), License Agreement (Biohaven Pharmaceutical Holding Co Ltd.)